Our Approach

our approach

Our advisory work starts from a position of respect
for our clients' organization, people,
products and science.

OUR RELATIONSHIPS

our approach

We have devoted our careers to the life
sciences industry and have the deepest respect
and admiration for the participants in it.

OUR TRACK RECORD

our approach

We are a very active advisor in the market.
Torreya Partners has successfully closed over
100 assignments since our founding in 2007.

Our Perspective

our approach

We often take an operating perspective
to strategic and transaction work.

PDI

Acquisition Financing from SWK Holdings

$20 million

December 2014

North America

PDI

Acquisition of Redpath Integrated Pathology

Up to $35 million

December 2014

North America

Sandoz

Divestiture of Certain ANDAs to IDT Australia

Up to $18 million

October 2014

North America

August 12-13, 2015

Canaccord Genuity Conf

Boston, MA

August 19-21, 2015

SALSS

Stockholm, Sweden

August 29 - September 2, 2015

ESC Congress

London, UK

November 3, 2014

PDI Expands Molecular Diagnostics Business with RedPath Integrated Pathology Acquisition

MORE

October 23, 2014

Medivation Inc. Licenses Clinical Stage Anti-PD-1 Immune Modulatory Monoclonal Antibody From CureTech Ltd. for Potential Applications in Oncology

MORE

October 23, 2014

Probiodrug Raises €22.5 Million in Successful Initial Public Offering and Listing on Euronext Amsterdam

MORE